| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Operating Expense | 3,286.00 | 2,996.40 | 2,852.90 | 2,575.70 |
| Other Net | 1.10 | 4.70 | 0.10 | - |
| Diluted Weighted Average Shares | 40.27 | 40.23 | 40.20 | 40.36 |
| Gain( Loss)on Saleof Assets | -2.80 | -2.90 | -2.50 | -7.50 |
| Depreciation/ Amortization | 446.30 | 425.80 | 418.80 | 359.70 |
| Operating Income | 452.70 | 646.00 | 635.70 | 617.20 |
| Net Income | 316.70 | 496.20 | 510.00 | 464.40 |
| Income Availableto Com Excl Extra Ord | 316.70 | 496.20 | 510.00 | 464.40 |
| Other Operating Expenses Total | 22.00 | 21.40 | - | - |
| Net Income Before Taxes | 410.90 | 659.90 | 620.80 | 593.60 |
| Interest Exp( Inc) Net- Operating Total | 6.60 | 6.80 | 7.10 | 6.80 |
| Net Income After Taxes | 316.70 | 496.20 | 510.00 | 464.40 |
| Income Availableto Com Incl Extra Ord | 316.70 | 496.20 | 510.00 | 464.40 |
| Costof Revenue Total | 991.80 | 1,011.50 | 999.90 | 929.40 |
| Gross Profit | 2,746.90 | 2,630.90 | 2,488.70 | 2,263.50 |
| Interest Inc( Exp) Net- Non- Op Total | -40.10 | 12.10 | -12.50 | -16.10 |
| Unusual Expense( Income) | 76.60 | -32.00 | 11.10 | 0.00 |
| Diluted Net Income | 316.70 | 496.20 | 510.00 | 464.40 |
| DPS- Common Stock Primary Issue | 1.25 | 1.25 | 1.25 | 0.50 |
| Provisionfor Income Taxes | 94.20 | 163.70 | 110.80 | 129.20 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 316.70 | 496.20 | 510.00 | 464.40 |
| Total Revenue | 3,738.70 | 3,642.40 | 3,488.60 | 3,192.90 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 3,738.70 | 3,642.40 | 3,488.60 | 3,192.90 |
| Selling/ General/ Admin Expenses Total | 1,742.70 | 1,562.90 | 1,416.00 | 1,279.80 |
| Diluted Normalized EPS | 9.39 | 11.79 | 12.97 | 11.65 |
| Diluted EPS Excluding Extra Ord Items | 7.87 | 12.33 | 12.69 | 11.51 |
Syngene International Dividend Syngene International Bonus Syngene International News Syngene International AGM Syngene International Rights Syngene International Splits Syngene International Board Meetings Syngene International Key Metrics Syngene International Shareholdings Syngene International Balance Sheet Syngene International Cashflow Syngene International Q1 Results Syngene International Q2 Results Syngene International Q3 Results Syngene International Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.